home > research channels > sectors > pharma


Latest News
31-Mar-2017 Indian Cos Vie for Novartis' Respiratory Brands
22-Mar-2017 US Ban on Divi's Labs may Dent Profits by Up to 25%
20-Mar-2017 Daiichi's Ranbaxy Profits Outweigh Losses: Singhs
15-Mar-2017 Sun's Mohali Facility Out of FDA Cloud
  more...
Latest Reports
May-17 IPM delivered moderate growth in April 2017 - Motilal Oswal  
May-17 US pricing pressure steeper than expected - ICICI direct.com  
May-17 India PharmaScope - Religare Research  
May-17 Time for Indian Pharma R&D Ratings to shift its gears to match with the global players - CARE Research  
  more...

Quarterly Summary (March Quarter)
Desc Current Previous Per.Chg
Sales 11947.9 11847.2 0.9
Otherincome 315.2 447.3 -29.5
Expense 9771.8 9604.2 1.7
RawMaterial 3222.2 3482.2 -7.5
StaffCost 1802.7 1753.5 2.8
ExciseDuty 65.0 19.0 242.8
OtherExp 3568.6 3407.8 4.7
Interest 401.7 455.8 -11.9
GrossProfit 2368.0 2662.7 -11.1
Depreciation 603.5 562.8 7.2
Tax 33.9 224.1 -84.9
NetProfit 1502.6 1595.5 -5.8
Total.Comp 36 -- --
Source: ETIG Database

Sectoral Companies As on 24 May 2017
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 144689.79
Lupin 55446.81
Piramal Entp 45718.85
Cadila Healt 45134.93
Cipla 41864.76
Dr.Reddy's 41775.60
Aurobindo Ph 30783.19
Alkem Labora 21872.87
Torrent Phar 20945.21
GlaxoSmith.P 20324.61
Biocon 17886.00
Glenmark Pha 17840.68
Natco Pharma 15490.91
  click here for the complete list